Not applicableStudy completedNCT02037256
What this trial is testing
Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma
Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisB-cell Chronic Lymphocytic LeukemiaContiguous Stage II Adult Burkitt Lymphoma+86 more
Barbara Ann Karmanos Cancer Institute 23